Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis

被引:9
作者
Suen, Christopher F. D. Li Wai [1 ,2 ]
Seah, Dean [1 ]
Choy, Matthew C. [1 ,2 ]
De Cruz, Peter [1 ,2 ,3 ]
机构
[1] Austin Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Univ Melbourne, Austin Acad Ctr, Dept Med, Melbourne, Vic, Australia
[3] Austin Hlth, Dept Gastroenterol, 145 Studley Rd, Heidelberg, Vic 3084, Australia
关键词
acute severe ulcerative colitis; infliximab; cyclosporin; colectomy; prognosis; LONG-TERM OUTCOMES; INTRAVENOUS CYCLOSPORINE; HOSPITALIZED-PATIENTS; INFLIXIMAB INDUCTION; PREDICTIVE FACTORS; FECAL CALPROTECTIN; ENDOSCOPIC SCORE; COLECTOMY RATES; FOLLOW-UP; EFFICACY;
D O I
10.1093/ibd/izad183
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Acute severe ulcerative colitis (ASUC) is a medical emergency for which colectomy is required in patients who do not respond to rescue therapy. While previous studies have predominantly focused on predicting outcome to first-line corticosteroid therapy, there is a need to understand the factors associated with response to rescue therapies in order to improve clinical outcomes. We reviewed the evidence regarding factors associated with response to rescue therapy in adults with ASUC and identified future directions for research.Methods A systematic search of the literature was conducted, and 2 reviewers independently assessed studies for inclusion.Results Of 3509 records screened, 101 completed studies were eligible for inclusion. We identified 42 clinical, hematological, biochemical, endoscopic, or pharmacological factors associated with response to rescue therapy. Older age (& GE;50 years), thiopurine experience, and cytomegalovirus or Clostridioides difficile infection were associated with a higher risk of nonresponse to rescue therapy. Biochemical factors associated with poorer response included an elevated C-reactive protein (CRP) & GE;30mg/L on admission, hypoalbuminemia and an elevated ratio of CRP to albumin. Severe endoscopic findings, including a Mayo endoscopic score of 3 or Ulcerative Colitis Endoscopic Index of Severity & GE;5, portended poorer outcomes. The role of fecal calprotectin and therapeutic value of measuring infliximab drug levels in ASUC remain to be defined.Conclusions Response to rescue therapy can be predicted by several specific factors, which would aid clinical decision-making. Existing and emerging factors should be integrated within predictive and prognostic models to help improve clinical outcomes. In this review, we summarize the clinical, hematological, biochemical, radiological, endoscopic, and drug-related factors that predict or are associated with response to rescue therapy in patients with acute severe ulcerative colitis. We also provide a clinical algorithm for clinicians. Graphical Abstract
引用
收藏
页码:1389 / 1405
页数:17
相关论文
共 111 条
[31]  
GENIUS, 2019, MULT PROSP COH STUD
[32]   Comparison of medium to long-term outcomes of acute severe ulcerative colitis patients receiving accelerated and standard infliximab induction [J].
Gibson, David J. ;
Doherty, Jayne ;
McNally, Mairead ;
Campion, John ;
Keegan, Denise ;
Keogh, Aine ;
Kennedy, Una ;
Byrne, Kathryn ;
Egan, Laurence J. ;
McKiernan, Susan ;
MacCarthy, FInbar ;
Sengupta, Subhasish ;
Sheridan, Juliette ;
Mulcahy, Hugh E. ;
Cullen, Garret ;
Slattery, Eoin ;
Kevans, David ;
Doherty, Glen A. .
FRONTLINE GASTROENTEROLOGY, 2020, 11 (06) :441-447
[33]   An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis [J].
Gibson, David J. ;
Heetun, Zaid S. ;
Redmond, Ciaran E. ;
Nanda, Kavin S. ;
Keegan, Denise ;
Byrne, Kathryn ;
Mulcahy, Hugh E. ;
Cullen, Garret ;
Doherty, Glen A. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (02) :330-U170
[34]  
Gilhotra RA, 2018, J GASTROEN HEPATOL, V33, P93
[35]   Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center [J].
Govani, Shail M. ;
Berinstein, Jeffrey A. ;
Waljee, Akbar K. ;
Stidham, Ryan W. ;
Higgins, Peter D. R. ;
Hardiman, Karin M. .
DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (06) :1800-1805
[36]   Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study [J].
Grazie, Marco Le ;
Bagnoli, Siro ;
Dragoni, Gabriele ;
Caini, Saverio ;
Annese, Vito ;
Innocenti, Tommaso ;
Deiana, Simona ;
Manetti, Natalia ;
Milani, Stefano ;
Galli, Andrea ;
Milla, Monica .
ANNALS OF GASTROENTEROLOGY, 2021, 34 (03) :370-377
[37]   THERE IS NO DIFFERENCE IN SHORT-TERM COLECTOMY RATE BETWEEN INFLIXIMAB-EXPOSED AND INFLIXIMAB-NAIVE HOSPITALIZED ULCERATIVE COLITIS PATIENTS [J].
Gupta, Sanchit ;
Shah, Shailja ;
Naymagon, Steven ;
Panchal, Hinaben J. ;
Sands, Bruce E. ;
Cohen, Benjamin L. ;
Dubinsky, Marla .
GASTROENTEROLOGY, 2017, 152 (05) :S396-S396
[38]   Predicting Outcome in Acute Severe Colitis - Controversies in Clinical Practice in 2021 [J].
Gupta, Vipin ;
Mohsen, Waled ;
Chapman, Thomas P. ;
Satsangi, Jack .
JOURNAL OF CROHNS & COLITIS, 2021, 15 (07) :1211-1221
[39]  
Gupta V, 2020, GASTROENTEROLOGY, V158, pS704
[40]   Clinical trial: colectomy after rescue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infliximab study [J].
Gustavsson, A. ;
Jarnerot, G. ;
Hertervig, E. ;
Friis-Liby, I. ;
Blomquist, L. ;
Karlen, P. ;
Granno, C. ;
Vilien, M. ;
Strom, M. ;
Verbaan, H. ;
Hellstrom, P. M. ;
Magnuson, A. ;
Halfvarson, J. ;
Tysk, C. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (08) :984-989